Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma

Journal of Radiation Research

Volumn 56, Issue 3, 2015, Pages 561-567

  Yamashita, Hideomi ^a   Onishi, Hiroshi ^b   Murakami, Naoya ^c   Matsumoto, Yasuo ^d   Matsuo, Yukinori ^e   Nomiya, Takuma ^f   Nakagawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f YAMAGATA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; SBRT; Stereotactic body radiotherapy

Indexed keywords

MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

HEPATOCELLULAR CARCINOMA; LIVER TUMORS; OVERALL SURVIVAL; PREDICTIVE FACTORS; PRIMARY HEPATOCELLULAR CARCINOMA; PROGRESSION FREE SURVIVAL; STAGE I; STEREOTACTIC BODY RADIOTHERAPY; SURGICAL RESECTION;

ABLATION;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; FEMALE; HUMAN; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PREVENTION AND CONTROL; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDY; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84929934716     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rru130     Document Type: Article

References (26)

1. Higuchi M, Tanaka E, Kiyosawa K. Epidemiology and clinical aspects on hepatitis C. Jpn J Infect Dis 2002;55:69-77.
2. Arii S, Sata M, Sakamoto M, et al. Management of hepatocellular carcinoma: report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 2010;40:667-85.
3. Nouhaud E, Créhange G, Cueff A, et al. Stereotactic body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy. BMC Res Notes 2013;6:492.
4. Yamashita H, Nakagawa K, Shiraishi K, et al. Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study. J Gastroenterol Hepatol 2007;22: 523-7.
5. Garrean S, Hering J, Saied A, et al. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008;195:508-20.
6. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiationinduced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53:810-21.
7. Ikai I, Kudo M, Arii S, et al. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010;40:1043-59.
8. Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging 2009;34:371-80.
9. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984-92.
10. Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54: 1151-6.
11. Yamashita H, Nakagawa K, Shiraishi K, et al. External beam radiotherapy to treat intra-and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. J Gastroenterol Hepatol 2006;21:1555-60.
12. Yamashita H, Onishi H, Matsumoto Y, et al. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Radiat Oncol 2014;9:112.
13. Murakami T, Imai Y, Okada M, et al. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions. Oncology 2011;81 Suppl 1:86-99.
14. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
15. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.
16. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52-60.
17. Andolino DL, Johnson CS, Maluccio M, et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011;81:e447-53.
18. Louis C, Dewas S, Mirabel X, et al. Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. Technol Cancer Res Treat 2010;9:479-87.
19. Nouhaud E, Créhange G, Cueff A, et al. Stereotactic body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy. BMC Res Notes 2013;6:492.
20. Ibarra RA, Rojas D, Snyder L, et al. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol 2012;51:575-83.
21. Bujold A, Massey CA, Kim JJ, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 2013;31:1631-9.
22. Cardenes HR, Price TR, Perkins SM, et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 2010;12:218-25.
23. Takeda A, Sanuki N, Eriguchi T, et al. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. J Gastroenterol Hepatol 2014;29:372-9.
24. Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of longterm survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001;19:3037-44.
25. Arii S, Tanaka J, Yamazoe Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992;69:913-9.
26. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38:200-7.